ArticleMetabolites2026
Exploratory Analysis of Gut Microbiome and Metabolic Profile Changes Following Lenvatinib and Anti-PD-1 Combination Therapy in Liver Cancer.
Rui Zhong, Zhikun Lin, Binghui Jin, Xiaolin Wang, Hua Mu, Jinlong Hu, Qi Li, Peng Dou, Xinyu Liu, Chunxiu Hu and 2 more
Abstract read
In one paragraphArticle in Metabolites, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Rui ZhongDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Zhikun LinDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Binghui JinDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Xiaolin WangMetabolomics Subcenter of the National Genomics Data Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.
Hua MuDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Jinlong HuWest China Hospital, Sichuan University, Chengdu 610041, China.
Qi LiMetabolomics Subcenter of the National Genomics Data Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.ORCID 0009-0007-9363-3155 Peng DouMetabolomics Subcenter of the National Genomics Data Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.
Xinyu LiuMetabolomics Subcenter of the National Genomics Data Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.ORCID 0000-0002-0564-7167 Chunxiu HuMetabolomics Subcenter of the National Genomics Data Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.ORCID 0000-0002-4335-9895 Guowang XuMetabolomics Subcenter of the National Genomics Data Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.ORCID 0000-0003-4298-3554 Guang TanDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.ORCID 0000-0002-3591-8685 Funding
The Medical and Industry Joint Innovation Programs DMU-1&DICP UN202203The National Natural Science Foundation of China No. 81972217
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
anti-PD-1gut microbiotahepatocellular carcinomalenvatinibmetabolites
Identifiers
PMID41745580
PMCPMC12943127
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390